Methylene Blue is a redox-active compound with a range of pharmacological properties, including antioxidant, neuroprotective, and mitochondrial-supporting effects. Originally developed as a dye, it is now being explored for cognitive enhancement, improved cellular respiration, and potential applications in neurodegenerative conditions.

This is a compounded preparation. Compounded preparations are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety, efficacy, or quality.